These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
494 related items for PubMed ID: 22434522
1. Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway. Chen LC, Tu SH, Huang CS, Chen CS, Ho CT, Lin HW, Lee CH, Chang HW, Chang CH, Wu CH, Lee WS, Ho YS. Breast Cancer Res Treat; 2012 Aug; 134(3):989-1004. PubMed ID: 22434522 [Abstract] [Full Text] [Related]
2. Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. Payne SL, Fogelgren B, Hess AR, Seftor EA, Wiley EL, Fong SF, Csiszar K, Hendrix MJ, Kirschmann DA. Cancer Res; 2005 Dec 15; 65(24):11429-36. PubMed ID: 16357151 [Abstract] [Full Text] [Related]
3. Active lysyl oxidase (LOX) correlates with focal adhesion kinase (FAK)/paxillin activation and migration in invasive astrocytes. Laczko R, Szauter KM, Jansen MK, Hollosi P, Muranyi M, Molnar J, Fong KS, Hinek A, Csiszar K. Neuropathol Appl Neurobiol; 2007 Dec 15; 33(6):631-43. PubMed ID: 17931358 [Abstract] [Full Text] [Related]
4. A molecular role for lysyl oxidase in breast cancer invasion. Kirschmann DA, Seftor EA, Fong SF, Nieva DR, Sullivan CM, Edwards EM, Sommer P, Csiszar K, Hendrix MJ. Cancer Res; 2002 Aug 01; 62(15):4478-83. PubMed ID: 12154058 [Abstract] [Full Text] [Related]
5. [Mechanism of lysyl oxidase (LOX) in breast cancer invasion and metastasis]. Liu JL, Wei W, Tang W, Jiang Y, Yang HW, Li JT. Zhonghua Yi Xue Za Zhi; 2012 May 29; 92(20):1379-83. PubMed ID: 22883193 [Abstract] [Full Text] [Related]
6. Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migration. Postovit LM, Abbott DE, Payne SL, Wheaton WW, Margaryan NV, Sullivan R, Jansen MK, Csiszar K, Hendrix MJ, Kirschmann DA. J Cell Biochem; 2008 Apr 01; 103(5):1369-78. PubMed ID: 17685448 [Abstract] [Full Text] [Related]
7. Expression of lysyl oxidase in human osteosarcoma and its clinical significance: a tumor suppressive role of LOX in human osteosarcoma cells. Xu X, Wang B, Xu Y. Int J Oncol; 2013 Nov 01; 43(5):1578-86. PubMed ID: 23970168 [Abstract] [Full Text] [Related]
9. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma. Sakai M, Kato H, Sano A, Tanaka N, Inose T, Kimura H, Sohda M, Nakajima M, Kuwano H. Ann Surg Oncol; 2009 Sep 01; 16(9):2494-501. PubMed ID: 19526206 [Abstract] [Full Text] [Related]
10. Inositol hexaphosphate (IP6) inhibits key events of cancer metastasis: II. Effects on integrins and focal adhesions. Tantivejkul K, Vucenik I, Shamsuddin AM. Anticancer Res; 2003 Sep 01; 23(5A):3681-9. PubMed ID: 14666664 [Abstract] [Full Text] [Related]
11. Neutrophil granulocytes promote the migratory activity of MDA-MB-468 human breast carcinoma cells via ICAM-1. Strell C, Lang K, Niggemann B, Zaenker KS, Entschladen F. Exp Cell Res; 2010 Jan 01; 316(1):138-48. PubMed ID: 19747913 [Abstract] [Full Text] [Related]
13. Inhibition of Src activation with cardiotoxin III blocks migration and invasion of MDA-MB-231 cells. Tsai PC, Chu CL, Chiu CC, Chang LS, Lin SR. Toxicon; 2013 Nov 01; 74():56-67. PubMed ID: 23933586 [Abstract] [Full Text] [Related]
14. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo. Ma JG, Huang H, Chen SM, Chen Y, Xin XL, Lin LP, Ding J, Liu H, Meng LH. Breast Cancer Res Treat; 2011 Nov 01; 130(1):85-96. PubMed ID: 21181437 [Abstract] [Full Text] [Related]
15. Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma. Madan R, Smolkin MB, Cocker R, Fayyad R, Oktay MH. Hum Pathol; 2006 Jan 01; 37(1):9-15. PubMed ID: 16360410 [Abstract] [Full Text] [Related]
16. MLK3 regulates paxillin phosphorylation in chemokine-mediated breast cancer cell migration and invasion to drive metastasis. Chen J, Gallo KA. Cancer Res; 2012 Aug 15; 72(16):4130-40. PubMed ID: 22700880 [Abstract] [Full Text] [Related]
18. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R. Int J Oncol; 2004 Mar 15; 24(3):591-608. PubMed ID: 14767544 [Abstract] [Full Text] [Related]
19. Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells. Hochgräfe F, Zhang L, O'Toole SA, Browne BC, Pinese M, Porta Cubas A, Lehrbach GM, Croucher DR, Rickwood D, Boulghourjian A, Shearer R, Nair R, Swarbrick A, Faratian D, Mullen P, Harrison DJ, Biankin AV, Sutherland RL, Raftery MJ, Daly RJ. Cancer Res; 2010 Nov 15; 70(22):9391-401. PubMed ID: 20861192 [Abstract] [Full Text] [Related]
20. Retinoic acid increases tyrosine phosphorylation of focal adhesion kinase and paxillin in MCF-7 human breast cancer cells. Zhu WY, Jones CS, Amin S, Matsukuma K, Haque M, Vuligonda V, Chandraratna RA, De Luca LM. Cancer Res; 1999 Jan 01; 59(1):85-90. PubMed ID: 9892191 [Abstract] [Full Text] [Related] Page: [Next] [New Search]